We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $57.3B
1-Year Est. Return 18.32%
This Fund
S&P 500
This Quarter Est. Return
+10.17%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$29B
AUM Growth
+$2.88B
Cap. Flow
+$429M
Cap. Flow %
1.48%
Top 10 Hldgs %
23.49%
Holding
2,872
New
237
Increased
1,222
Reduced
1,098
Closed
217
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFSC icon
2351
Enterprise Financial Services Corp
EFSC
$2.41B
$213K ﹤0.01%
4,767
-636
-12% -$24.8K
ALNT icon
2352
Allient
ALNT
$1.45B
$213K ﹤0.01%
+7,037
New +$199K
FCF icon
2353
First Commonwealth Financial
FCF
$2.13B
$212K ﹤0.01%
13,754
+574
+4% +$7.67K
BKU icon
2354
Bankunited
BKU
$3.39B
$212K ﹤0.01%
+6,547
New +$170K
VYGR icon
2355
Voyager Therapeutics
VYGR
$184M
$212K ﹤0.01%
25,151
+3,151
+14% +$22.9K
LBTYK icon
2356
Liberty Global Class C
LBTYK
$3.32B
$212K ﹤0.01%
11,385
-2,032
-15% -$35.2K
DIVO icon
2357
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.49B
$212K ﹤0.01%
5,801
+1
+0% +$35
BATRK icon
2358
Atlanta Braves Holdings Series B
BATRK
$3.26B
$212K ﹤0.01%
+5,355
New +$195K
NNAG
2359
DELISTED
99 Acquisition Group Inc
NNAG
$212K ﹤0.01%
+20,764
New +$211K
KRP icon
2360
Kimbell Royalty Partners
KRP
$1.46B
$211K ﹤0.01%
14,050
+100
+0.7% +$1.57K
RWJ icon
2361
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.06B
$211K ﹤0.01%
+5,102
New +$188K
TKO icon
2362
TKO Group
TKO
$13.8B
$211K ﹤0.01%
2,588
-892
-26% -$70.8K
PJP icon
2363
Invesco Pharmaceuticals ETF
PJP
$443M
$210K ﹤0.01%
2,765
BKE icon
2364
Buckle
BKE
$2.25B
$210K ﹤0.01%
+4,424
New +$167K
CVNA icon
2365
Carvana
CVNA
$45.7B
$210K ﹤0.01%
+19,850
New +$149K
PCRX icon
2366
Pacira BioSciences
PCRX
$1.04B
$210K ﹤0.01%
+6,219
New +$182K
SLP icon
2367
Simulations Plus
SLP
$371M
$210K ﹤0.01%
+4,683
New +$186K
STRS icon
2368
Stratus Properties
STRS
$157M
$210K ﹤0.01%
+7,261
New +$198K
NKSH icon
2369
National Bankshares
NKSH
$244M
$209K ﹤0.01%
+6,451
New +$173K
EMF
2370
Templeton Emerging Markets Fund
EMF
$314M
$208K ﹤0.01%
17,845
-2,759
-13% -$31.4K
DIOD icon
2371
Diodes
DIOD
$3.88B
$208K ﹤0.01%
2,585
-1,332
-34% -$97.3K
LVHD icon
2372
Franklin US Low Volatility High Dividend Index ETF
LVHD
$636M
$208K ﹤0.01%
5,726
-689
-11% -$23.8K
TNDM icon
2373
Tandem Diabetes Care
TNDM
$1.15B
$207K ﹤0.01%
+7,014
New +$146K
SRCL
2374
DELISTED
Stericycle Inc
SRCL
$207K ﹤0.01%
4,181
-1,366
-25% -$61.3K
AMPH icon
2375
Amphastar Pharmaceuticals
AMPH
$844M
$207K ﹤0.01%
+3,346
New +$176K

Similar funds

CAPTRUST Financial Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, CAPTRUST Financial Advisors held 2,872 positions worth $29B, up 11% from $26.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

CAPTRUST Financial Advisors's Q4 2023 filing shows 237 new, 1,222 increased, 1,098 reduced and 217 closed positions. Its largest new stake was John Hancock Multifactor Mid Cap ETF: 580,824 shares worth $30.6M. The largest sale was iShares iBonds Dec 2023 Term Treasury ETF, an estimated $457M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • CAPTRUST Financial Advisors's largest Q4 2023 buy was John Hancock Multifactor Mid Cap ETF: 580,824 shares worth $30.6M.
  • CAPTRUST Financial Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q4 2023, an estimated $316M increase.
  • CAPTRUST Financial Advisors's biggest Q4 2023 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $302M.
  • CAPTRUST Financial Advisors fully exited iShares iBonds Dec 2023 Term Treasury ETF in Q4 2023, selling an estimated $457M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 23% of its $29B portfolio in Q4 2023.
  • CAPTRUST Financial Advisors opened 237 new positions and closed 217 in Q4 2023.
  • CAPTRUST Financial Advisors's portfolio value rose 11% quarter-over-quarter to $29B.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.